Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 2
2005 5
2006 4
2007 4
2008 2
2009 11
2010 4
2011 4
2012 6
2013 9
2014 16
2015 8
2016 7
2017 13
2018 5
2019 8
2020 8
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

111 results
Results by year
Filters applied: . Clear all
Page 1
Testing for ROS1 in non-small cell lung cancer: a review with recommendations.
Bubendorf L, Büttner R, Al-Dayel F, Dietel M, Elmberger G, Kerr K, López-Ríos F, Marchetti A, Öz B, Pauwels P, Penault-Llorca F, Rossi G, Ryška A, Thunnissen E. Bubendorf L, et al. Among authors: marchetti a. Virchows Arch. 2016 Nov;469(5):489-503. doi: 10.1007/s00428-016-2000-3. Epub 2016 Aug 17. Virchows Arch. 2016. PMID: 27535289 Free PMC article. Review.
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives.
Gori S, Barberis M, Bella MA, Buttitta F, Capoluongo E, Carrera P, Colombo N, Cortesi L, Genuardi M, Gion M, Guarneri V, Incorvaia L, La Verde N, Lorusso D, Marchetti A, Marchetti P, Normanno N, Pasini B, Pensabene M, Pignata S, Radice P, Ricevuto E, Sapino A, Tagliaferri P, Tassone P, Trevisiol C, Truini M, Varesco L, Russo A; AIOM-SIGU-SIBIOC-SIAPEC-IAP Working Group. Gori S, et al. Among authors: marchetti a. Crit Rev Oncol Hematol. 2019 Aug;140:67-72. doi: 10.1016/j.critrevonc.2019.05.012. Epub 2019 May 25. Crit Rev Oncol Hematol. 2019. PMID: 31176273 Free article.
2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.
Eberhardt WE, De Ruysscher D, Weder W, Le Péchoux C, De Leyn P, Hoffmann H, Westeel V, Stahel R, Felip E, Peters S; Panel Members. Eberhardt WE, et al. Ann Oncol. 2015 Aug;26(8):1573-88. doi: 10.1093/annonc/mdv187. Epub 2015 Apr 20. Ann Oncol. 2015. PMID: 25897013 Free article. Review.
Correlation of ROS1 Immunohistochemistry With ROS1 Fusion Status Determined by Fluorescence In Situ Hybridization.
Huang RSP, Smith D, Le CH, Liu WW, Ordinario E, Manohar C, Lee M, Rajamani J, Truong H, Li J, Choi C, Li J, Pati A, Bubendorf L, Buettner R, Kerr KM, Lopez-Rios F, Marchetti A, Marondel I, Nicholson AG, Öz AB, Pauwels P, Penault-Llorca F, Rossi G, Thunnissen E, Newell AH, Pate G, Menzl I. Huang RSP, et al. Among authors: marchetti a. Arch Pathol Lab Med. 2020 Jun;144(6):735-741. doi: 10.5858/arpa.2019-0085-OA. Epub 2019 Sep 11. Arch Pathol Lab Med. 2020. PMID: 31509456 Free article.
The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies.
Lin L, Sabnis AJ, Chan E, Olivas V, Cade L, Pazarentzos E, Asthana S, Neel D, Yan JJ, Lu X, Pham L, Wang MM, Karachaliou N, Cao MG, Manzano JL, Ramirez JL, Torres JM, Buttitta F, Rudin CM, Collisson EA, Algazi A, Robinson E, Osman I, Muñoz-Couselo E, Cortes J, Frederick DT, Cooper ZA, McMahon M, Marchetti A, Rosell R, Flaherty KT, Wargo JA, Bivona TG. Lin L, et al. Among authors: marchetti a. Nat Genet. 2015 Mar;47(3):250-6. doi: 10.1038/ng.3218. Epub 2015 Feb 9. Nat Genet. 2015. PMID: 25665005 Free PMC article.
An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments.
Marchetti A, Di Lorito A, Felicioni L, Buttitta F. Marchetti A, et al. Oncotarget. 2019 Dec 10;10(65):6957-6968. doi: 10.18632/oncotarget.27343. eCollection 2019 Dec 10. Oncotarget. 2019. PMID: 31857850 Free PMC article.
Guidance for laboratories performing molecular pathology for cancer patients.
Cree IA, Deans Z, Ligtenberg MJ, Normanno N, Edsjö A, Rouleau E, Solé F, Thunnissen E, Timens W, Schuuring E, Dequeker E, Murray S, Dietel M, Groenen P, Van Krieken JH; European Society of Pathology Task Force on Quality Assurance in Molecular Pathology; Royal College of Pathologists. Cree IA, et al. J Clin Pathol. 2014 Nov;67(11):923-31. doi: 10.1136/jclinpath-2014-202404. Epub 2014 Jul 10. J Clin Pathol. 2014. PMID: 25012948 Free PMC article. Review.
Clinical features and outcome of patients with non-small-cell lung cancer harboring BRAF mutations.
Marchetti A, Felicioni L, Malatesta S, Grazia Sciarrotta M, Guetti L, Chella A, Viola P, Pullara C, Mucilli F, Buttitta F. Marchetti A, et al. J Clin Oncol. 2011 Sep 10;29(26):3574-9. doi: 10.1200/JCO.2011.35.9638. Epub 2011 Aug 8. J Clin Oncol. 2011. PMID: 21825258
Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment.
Buttitta F, Felicioni L, Lorito AD, Cortellini A, Irtelli L, Brocco D, Marino PD, Traisci D, D'Ostilio N, Paolo AD, Malorgio F, Assalone P, Felice SD, Fabbri F, Cianci G, Tursi M, Marchetti A. Buttitta F, et al. Among authors: marchetti a. Oncotarget. 2020 Mar 17;11(11):982-991. doi: 10.18632/oncotarget.27517. eCollection 2020 Mar 17. Oncotarget. 2020. PMID: 32215186 Free PMC article.
Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice.
Fassan M, Scarpa A, Remo A, De Maglio G, Troncone G, Marchetti A, Doglioni C, Ingravallo G, Perrone G, Parente P, Luchini C, Mastracci L. Fassan M, et al. Among authors: marchetti a. Pathologica. 2020 Sep;112(3):248-259. doi: 10.32074/1591-951X-158. Pathologica. 2020. PMID: 33179625 Free article. Review.
111 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback